PST-1

CAS No. 1801769-39-0

PST-1( —— )

Catalog No. M12744 CAS No. 1801769-39-0

PST-1 is a photoswitchable inhibitor of microtubule with EC50 of 0.5 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PST-1
  • Note
    Research use only, not for human use.
  • Brief Description
    PST-1 is a photoswitchable inhibitor of microtubule with EC50 of 0.5 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines.
  • Description
    PST-1 is a photoswitchable inhibitor of microtubule with EC50 of 0.5 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines; 100-fold more cytotoxic than in the dark.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    Microtubule/Tubulin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1801769-39-0
  • Formula Weight
    318.329
  • Molecular Formula
    C16H18N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    (Z)-2-methoxy-5-((3,4,5-trimethoxyphenyl)diazenyl)phenol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Borowiak M, et al. Cell. 2015 Jul 16;162(2):403-11.
molnova catalog
related products
  • CKD-516

    CKD-516 (Valecobulin, CKD516) is a potent beta-tubulin polymerization inhibitor with marked antitumor activity both in vitro and in vivo.

  • Parbendazole

    Parbendazole is a potent inhibitor of microtubule assembly(EC50 : 8.79?nM).Parbendazole is a carbamate ester-amine. It finds applications in control or treatment of nematode infestations.

  • VERU-111 analogue 13...

    VERU-111 analogue 13f is a novel potent colchicine binding site inhibitor (CBSI) in tubulin with potential anticancer activities.